FGF2 and neoplasm: IFN-α2a has also been shown to inhibit of cell growth and antiangiogenesis (Okada et al. 2001) and directly inhibit the release of tumor-derived pro-angiogenic factors such as VEGF and bFGF (von Marschall et al. 2003; Singh et al. 1995).